Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of NTM Antibiotics in Cystic Fibrosis
NCT02372383Completed
- Sponsor
- University of Colorado Denver
- Start
- Oct 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ethambutol, rifampicin and azithromycin in nontuberculous mycobacterial lung disease, sponsored by University of Colorado Denver. Started Oct 2014; status: completed.
02
Drugs
ethambutolrifampicinazithromycin
03
Conditions
nontuberculous mycobacterial lung disease
Beyond the preview
Go deeper on NCT02372383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02372383.